Increase of resting levels of superoxide anion in the whole blood of patients with decompensated liver cirrhosis

Free Radical Biology and Medicine

Volumn 23, Issue 4, 1997, Pages 672-679

  Chen, Ming Feng ^a   Mo, Lein Ray ^a   Lin, Ruey Chang ^a   Kuo, Jenn Yuan ^a   Chang, Kuo Kuan ^a   Liao, Chen ^a   Lu, Fung Jou ^b  

^a TAINAN MUNICIPAL HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Albumin; Bilirubin; Chemiluminescence; GOT; GPT; Liver cirrhosis; Lucigenin; Superoxide

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ANION; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; LUCIGENIN; SUPEROXIDE;

ADULT; ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; FEMALE; HUMAN; INFLAMMATION; LIVER CIRRHOSIS; LIVER FAILURE; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ACRIDINES; ADULT; ALANINE TRANSAMINASE; ANIONS; ASPARTATE AMINOTRANSFERASES; BILIRUBIN; CATALASE; CHEMILUMINESCENT MEASUREMENTS; FEMALE; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; SERUM ALBUMIN; SUPEROXIDE DISMUTASE; SUPEROXIDES;

EID: 0030743306     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(97)00057-9     Document Type: Article

References (34)

1. Burkitt J. M., Mason R. P. Direct evidence for in vivo hydroxyl-radical generation in experimental iron overload: An ESR spin-trapping investigation. Proc. Natl. Acad. Sci. USA. 88:1991;8440-8444.
2. Bacon B. R., Britton R. S. The pathology of hepatic iron overload. A free radical-mediated process? Hepatology. 11:1990;127-137.
3. Sokol R. J., Devereaux M., Mierau G. W., Hambidge M, Shikes R. H. Oxidant injury to hepatic mitochondria lipids in rats with dietary copper overload. Modification by vitamin E deficiency. Gastroenterology. 99:1990;1061-1071.
4. Yamada T., Sogawa K., Suzuki Y., Izumi K., Agui T., Matsumoto K. Elevation of the level of lipid peroxidation associated with hepatic injury in the LEC mutant rat. Res. Commun. Chem. Pathol. Pharmacol. 77:1992;121-124.
5. Reinke L. A., Lai E. K., DuBose C. M., McCay P. B. Reactive free radical generation in vivo in heart and liver of ethanol-fed rats: Correlation with radical formation in vitro. Proc. Natl. Acad. Sci. 84:1987;9223-9227.
6. Lieber C. S. Biochemical factors in alcoholic liver disease. Semin. Liver Dis. 13:1993;136-157.
7. Cederbaum A. I. Role of lipid peroxidation and oxidative stress in alcohol toxicity. Free Rad. Bio. Med. 7:1989;537-539.
8. Poyer J. L., McCay P. B., Lai E. K., Janzen E. G., Davis E. R. Confirmation of assignment of the tricholoromethyl radical spin adduct detected by spin trapping during 13C-carbon tetracholoride metabolism in vitro and in vivo. Biochem Biophys Res. Commun. 94:1980;1154-1160.
9. Horton A. A., Fairhurst S. Lipid peroxidation and mechanisms of toxicity. CBC Crit. Rev. Toxicol. 18:1987;27-79.
10. Friedman S. L. The cellular basis of hepatic fibrosis. Mechanism and treatment strategies. N. Engl. J. Med. 328:1989;1828-1835.
11. Chojkier M., Houglum K., Solis-Herruzo J., Brenner D. A. Stimulation of collagen gene expression by ascorbic acid in cultured human fibroblasts. A role for lipid peroxidation? J. Biol. Chem. 264:1989;16957-16962.
12. Tsukamoto H. C., Kim W., Lou Z. Z., Horn W., Su L. C., Brittenham G. M. Role of lipid peroxidation in vivo and in vitro models of liver fibrogenesis. Gastroenterology. 104:1993;A1012.
13. Li S. C. Y., Britton R. S., O'Neill R., Bacon B. R. The effect of malondialdehyde on collagen production by rat hepatic lipocytes. Gastroenterology. 104:1993;A939.
14. Esterbauer H. R, Schaur J., Zollner H. Chemistry and biochemistry of 4-hydroxynonental, malonaldehyde and related aldehydes. Free Rad. Biol. Med. 11:1991;81-128.
15. Shaw S., Rubin K. B., Lieber C. S. Depressed hepatic glutathione and increased diene conjugates in alcoholic liver disease. Evidence of lipid peroxidation. Dig. Dis. Sci. 28:1983;585-589.
16. Moscarella S., Laffi G., Buzzelli G., Mazzanti R, Caramelli L, Gentilini P. Expired hydrocarbons in patients with chronic liver disease. Gastroenterology. 31:1984;60-63.
17. Mazzanti R, Moscarella S., Bensi G., Altavilla E., Gentilini P. Hepatic lipid peroxidation and aldehyde dehydrogenase activity in alcoholic and nonalcoholic liver disease. Alcohol. 24:1989;121-128.
18. Moscrella S., Duchini A., Buzzelli G. Lipoperoxidation, trace elements and vitamin E in patients with liver cirrhosis. Eur. J. Gatroenterol. 6:1994;633-636.
19. Uehara M., Sato N. Impaired ability of neutrophils to produce oxygen-derived free radicals in patients with chronic liver disease and hepatocellular carcinoma. Hepatology. 20:1994;326-330.
20. Lu F. J., Lin J. T., Wang H. P., Huang W. C. A simple, sensitive, nonstimulated photon counting system for detection of superoxide anion in whole blood. Experientia. 52:1995;141-144.
21. Sun J. S., Hang Y. S., Huang I. H., Lu F. J. A simple chemiluminescence assay for detecting oxidative stress in ischemic limb injury. Free Rad. Biol. Med. 20:1996;107-112.
22. Tono-Oka T., Ueno N., Matsumato T., Ohkawa M., Matsumoto S. Chemiluminescence of whole blood. 1. A simple and rapid method for the estimation of phagocytic function of granulocytes and opsonic activity in whole blood. Clin. Immunol. Immunopathol. 26:1983;66-75.
23. Theron A. J., Steenkamp K. J., Anderson R. NADPH-oxidase activity of stimulated neutrophils is markedly increased by serum. Inflammation. 18:1994;459-467.
24. Hoffman T., Lizzio F. F. Albumin in monocyte function assays. Differential stimulation of superoxide or arachidonate release by calcium ionophores. J. Immunol. Methods. 112:1988;9-14.
25. Badwey J. A., Curnutte J. T., Robinson J. M., Berde C. B., Karnovsky M. J., Karnosky M. L. Effect of free fatty acids on release of superoxide and on change of shape by human neutrophils. Reversibility by albumin. Act. Pharmacol. Toxicol. 259:1984;7870-7877.
26. Dameron C. T., Harris E. D. Regulation of aortic Cu, Zn-superoxide dismutase with copper. Caeruloplasmin and albumin reactivate and transfer copper to the enzyme in culture. Biochem. J. 248:1987;669-675.
27. McCord J. M., Fridovieh J. Superoxide dismutase, an enzymic function for erythrocuprein (Hemocuprein). J. Biol. Chem. 244:1969;6049-6055.
28. Karaclyclin S., Arcasoy A., Uzunalimoglu O. Zinc plasma levels after oral zinc tolerance test in nonalcoholic cirrhosis. Dig. Dis. Sci. 33:1988;1096-1102.
29. McClain C. J., Su L. C. Zinc deficiency in the alcoholic: A review. Alcohol. Clin. Exp. Res. 7:1983;5-10.
30. Goode H. F., Kelleher J., Walker B. E. Relation between zinc status and hepatic function reserve in patients with liver disease. Gut. 31:1990;694-697.
31. Walker B. E., Dawson J. B., Kelleher J., Losowsky M. S. Plasma and urinary zinc in patients with malabsorption syndromes or hepatic cirrhosis. Gut. 14:1973;943-948.
32. Bode J. C., Hanisch P., Henning H., Koening W., Richter E. W., Bode C. Hepatic zinc content in patients with various stage of alcoholic liver disease and patients with chronic active and chronic persistent hepatitis. Hepatology. 8:1988;1605-1609.
33. Schlechter P. J., Giroux E. L., Schlienger J. L., Hoening V., Sjoerdsma A. Distribution of serum zinc between albumin and alpha-2-macroglobulin in patients with decompensated hepatic liver cirrhosis. Eur. J. Clin. Invest. 7:1977;71-73.
34. Giroux E., Schechter P. J., Shoun J., Sjoerdsma A. Reduced binding of added zinc in serum of patients with decompensated hepatic cirrhosis. Eur. J. Clin. Invest. 7:1977;71-79.